Close Menu

NEW YORK – The National Institutes of Health announced Monday it has awarded more than $107 million to projects aimed at addressing gaps in SARS-CoV-2 testing and surveillance using novel approaches.

Through a Rapid Acceleration of Diagnostics (RADx) initiative called RADx Radical, or RADx-rad, the NIH is supporting non-traditional approaches and reimagined uses of existing tools, in particular supporting 49 research projects and grant supplements at 43 US institutions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.